| Product NDC: | 52549-2085 |
| Proprietary Name: | Loratadine |
| Non Proprietary Name: | Loratadine |
| Active Ingredient(s): | 5 mg/5mL & nbsp; Loratadine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52549-2085 |
| Labeler Name: | Taro Pharmaceuticals Industries, Ltd. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA076805 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040820 |
| Package NDC: | 52549-2085-8 |
| Package Description: | 1 BOTTLE in 1 CARTON (52549-2085-8) > 120 mL in 1 BOTTLE |
| NDC Code | 52549-2085-8 |
| Proprietary Name | Loratadine |
| Package Description | 1 BOTTLE in 1 CARTON (52549-2085-8) > 120 mL in 1 BOTTLE |
| Product NDC | 52549-2085 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Loratadine |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20040820 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals Industries, Ltd. |
| Substance Name | LORATADINE |
| Strength Number | 5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes |